ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 OutlookGlobeNewsWire • 01/13/25
ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT ExclusivityGlobeNewsWire • 01/02/25
ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 12/30/24
ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare ConferenceGlobeNewsWire • 11/26/24
Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect?Zacks Investment Research • 11/26/24
ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Surpass EstimatesZacks Investment Research • 11/08/24
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 GuidanceGlobeNewsWire • 11/08/24
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in NovemberGlobeNewsWire • 11/04/24
Earnings Preview: ANI Pharmaceuticals (ANIP) Q3 Earnings Expected to DeclineZacks Investment Research • 11/01/24
ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ETGlobeNewsWire • 10/30/24
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%GlobeNewsWire • 10/25/24
ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024GlobeNewsWire • 10/24/24
ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong PotentialBenzinga • 10/11/24
Wall Street Analysts Predict a 42.98% Upside in ANI (ANIP): Here's What You Should KnowZacks Investment Research • 10/09/24
ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%GlobeNewsWire • 09/26/24
ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral SolutionGlobeNewsWire • 09/13/24